The American Heart Association is pioneering a comprehensive approach to diagnosing and treating cardiovascular-kidney-metabolic (CKM) syndrome through a new nationwide health initiative. Five U.S. regions have been chosen to implement a collaborative care model designed to improve patient outcomes for individuals with this complex, interconnected health condition.
The selected regions—Atlanta, Baton Rouge, San Diego, Washington D.C. and Maryland, and Ohio—will serve as pilot sites for an innovative strategy addressing the multifaceted nature of CKM syndrome. This condition encompasses heart disease, kidney disease, diabetes, and obesity, which collectively heighten risks of heart attack, stroke, and heart failure.
Approximately one in three U.S. adults experiences at least three components of CKM syndrome, including high blood pressure, elevated triglycerides, abnormal blood sugar, impaired kidney function, and excess body weight. The initiative aims to transform healthcare delivery by promoting an interdisciplinary approach that moves beyond traditional specialty-based treatment.
Dr. Chiadi Ndumele, chair of the initiative's science advisory group, emphasized the importance of a person-centered care model. The approach will integrate primary care clinicians, specialists, patient navigators, social workers, and community health workers to provide holistic patient care.
The program will initially impact over 250,000 patients across 150 healthcare sites, with plans to expand to 15 geographic regions. Key strategies include consistent health factor tracking, evidence-based therapies, connecting patients with community resources, and facilitating collaborative care among healthcare professionals.
Supported by sponsors Novo Nordisk, Boehringer Ingelheim, and DaVita, the initiative represents a significant step toward addressing the interconnected nature of chronic health conditions and promoting more comprehensive, patient-centered healthcare strategies.
